Affordable Access

deepdyve-link deepdyve-link
Publisher Website

New opportunities for the management and therapy of hepatitis C in correctional settings.

Authors
Type
Published Article
Journal
American Journal of Public Health
1541-0048
Publisher
American Public Health Association
Publication Date
Volume
100
Issue
1
Pages
13–17
Identifiers
DOI: 10.2105/AJPH.2008.147629
PMID: 20007626
Source
Medline
License
Unknown

Abstract

Hepatitis C in prison populations is now a major public health problem, and large numbers of correctional facilities have no comprehensive management program, often because of formidable projected costs and tightening budget constraints. The North Dakota Department of Corrections and Rehabilitation has operated a management and therapy program since 2002 using consensus interferon and ribavirin with 45% cost savings. The program has provided excellent sustained viral responses: 54.2% for genotype 1 hepatitis C, 75% for genotypes 2 and 3, and 63.6% overall.

Statistics

Seen <100 times